Business Description
Sensus Healthcare Inc
NAICS : 339112
SIC : 3841
ISIN : US81728J1097
Description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.65 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 15.12 | |||||
| Beneish M-Score | -0.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37 | |||||
| 3-Year FCF Growth Rate | -44.9 | |||||
| 3-Year Book Growth Rate | 31.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 195.98 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.76 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.85 | |||||
| 9-Day RSI | 45 | |||||
| 14-Day RSI | 44.52 | |||||
| 6-1 Month Momentum % | 79.65 | |||||
| 12-1 Month Momentum % | 261.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.52 | |||||
| Quick Ratio | 8.22 | |||||
| Cash Ratio | 4.33 | |||||
| Days Inventory | 291.6 | |||||
| Days Sales Outstanding | 127.96 | |||||
| Days Payable | 80.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 0.17 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.9 | |||||
| Operating Margin % | 28.91 | |||||
| Net Margin % | 22.54 | |||||
| FCF Margin % | 4.98 | |||||
| ROE % | 18.5 | |||||
| ROA % | 16.65 | |||||
| ROIC % | 26.69 | |||||
| ROC (Joel Greenblatt) % | 41.95 | |||||
| ROCE % | 23.44 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.72 | |||||
| Forward PE Ratio | 11.28 | |||||
| PE Ratio without NRI | 12.72 | |||||
| Shiller PE Ratio | 77.71 | |||||
| Price-to-Owner-Earnings | 71.08 | |||||
| PS Ratio | 2.86 | |||||
| PB Ratio | 2.19 | |||||
| Price-to-Tangible-Book | 2.24 | |||||
| Price-to-Free-Cash-Flow | 56.64 | |||||
| Price-to-Operating-Cash-Flow | 44.48 | |||||
| EV-to-EBIT | 8.08 | |||||
| EV-to-EBITDA | 8.01 | |||||
| EV-to-Revenue | 2.34 | |||||
| EV-to-Forward-Revenue | 1.96 | |||||
| EV-to-FCF | 46.35 | |||||
| Price-to-Projected-FCF | 6.21 | |||||
| Price-to-Graham-Number | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 2.48 | |||||
| Price-to-Net-Cash | 7.16 | |||||
| Earnings Yield (Greenblatt) % | 12.39 | |||||
| FCF Yield % | 1.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sensus Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 37.881 | ||
| EPS (TTM) (€) | 0.523 | ||
| Beta | 0.14 | ||
| Volatility % | 89.7 | ||
| 14-Day RSI | 44.52 | ||
| 14-Day ATR (€) | 0.14834 | ||
| 20-Day SMA (€) | 7.25 | ||
| 12-1 Month Momentum % | 261.5 | ||
| 52-Week Range (€) | 2.346 - 8.6 | ||
| Shares Outstanding (Mil) | 16.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sensus Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sensus Healthcare Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sensus Healthcare Inc Frequently Asked Questions
What is Sensus Healthcare Inc(FRA:5TX)'s stock price today?
The current price of FRA:5TX is €6.95. The 52 week high of FRA:5TX is €8.60 and 52 week low is €2.35.
When is next earnings date of Sensus Healthcare Inc(FRA:5TX)?
The next earnings date of Sensus Healthcare Inc(FRA:5TX) is 2025-02-07 Est..
Does Sensus Healthcare Inc(FRA:5TX) pay dividends? If so, how much?
Sensus Healthcare Inc(FRA:5TX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers